BiotechTube
Home/GreenJay Therapeutics/Vassil Tzenov
VT

Vassil Tzenov

Vice President and Chief Financial Officer

GreenJay Therapeutics

Therapeutic Areas

OncologyHematology

GreenJay Therapeutics Pipeline

DrugIndicationPhase
Bulanta™Conditioning agent for stem cell transplantation in Chronic Myelogenous Leukemia (CML)Pre-NDA

Leadership Team at GreenJay Therapeutics

LB
Lisa Bollinger, MD
Advisor (FDA Strategy)
View full GreenJay Therapeutics profile